Mizuho Initiates Coverage On Adverum Biotechnologies With Buy Rating, Announces Price Target of $2
Mizuho Initiates Coverage On Adverum Biotechnologies With Buy Rating, Announces Price Target of $2
瑞穗以買入評級啓動對副詞生物技術的報道,宣佈目標股價爲2美元
Mizuho analyst Graig Suvannavejh initiates coverage on Adverum Biotechnologies (NASDAQ:ADVM) with a Buy rating and announces Price Target of $2.
瑞穗分析師Graig Suvannavejh以買入評級開始報道Adverum Biotechnologies(納斯達克股票代碼:ADVM),並宣佈目標股價爲2美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。